In addition to lowering blood sugar levels, diabetes drugs called sodium-glucose cotransporter 2 (SGLT2) inhibitors can provide kidney- and cardiovascular-related
Continue reading »
mypharmacynews.com
Home »
In addition to lowering blood sugar levels, diabetes drugs called sodium-glucose cotransporter 2 (SGLT2) inhibitors can provide kidney- and cardiovascular-related
Continue reading »A new screening system developed by scientists at the UCLA Jonsson Comprehensive Cancer Center leverages redundancy in an important component
Continue reading »In an article recently published in JCI Insight, researchers from the University of Alabama at Birmingham and Vanderbilt University have
Continue reading »Ocular inflammation uveitis is a serious disease that can destroy eye tissue and cause irreversible blindness. Fortunately, blindness and eye
Continue reading »(HealthDay)—Myocarditis in patients treated with immune checkpoint inhibitors (ICIs) may be more common than previously thought, according to a study
Continue reading »